Bicycle Therapeutics Plc (BCYC)
4.17
+0.06
(+1.46%)
USD |
NASDAQ |
Jun 09, 14:04
Bicycle Therapeutics SG&A Expense (Quarterly) : 17.44M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| DBV Technologies SA | 15.36M |
| Akari Therapeutics Plc | 2.165M |
| Autolus Therapeutics Plc | 39.89M |
| Cellectis SA | 5.610M |
| Aptorum Group Ltd. | 0.2117M |